A personal voyage through the proteoglycan field

Matrix Biology

Volumn 35, Issue , 2014, Pages 3-7

  Lindahl, Ulf ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Chondroitin sulfate; Core proteins; GAGosome; Glycosaminoglycan biosynthesis; Glycosaminoglycan chain; Glycosaminoglycan protein interactions; Heparan sulfate

Indexed keywords

CORE PROTEIN; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; PROTEOGLYCAN;

AMINO ACID SEQUENCE; ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CELL MEMBRANE; CONNECTIVE TISSUE; ELECTROPHORESIS; EMBRYO DEVELOPMENT; EPIMERIZATION; EXTRACELLULAR MATRIX; GENOMICS; HUMAN; INFLAMMATION; MORPHOGENESIS; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAPER CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; TISSUE REPAIR; ANIMAL; CHEMISTRY; DISEASES; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE;

ANIMALS; DISEASE; GENOMICS; GLYCOSAMINOGLYCANS; GROWTH AND DEVELOPMENT; HUMANS; MICE; PROTEOGLYCANS;

EID: 84901456423     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2014.01.001     Document Type: Article

References (87)

1. Alexopoulou A.N., Multaupt H.A., Couchman J.R. Syndecans in wound healing, inflammation and vascular biology. Int. J. Biochem. Cell Biol. 2007, 39:505-528.
2. Bao X., Pavão M.S., Dos Santos J.C., Sugahara K. A functional dermatan sulfate epitope containing iduronate(2-O-sulfate)alpha1-3GalNAc(6-O-sulfate) disaccharide in the mouse brain: demonstration using a novel monoclonal antibody raised against dermatan sulfate of ascidian Ascidia nigra. J. Biol. Chem. 2005, 280:23184-23193.
3. Bernfield M., Götte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 1999, 68:729-777.
4. Bishop J.R., Schuksz M., Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446:1030-1037.
5. Bonnet F., Le Glédic S., Périn J.P., Jollès J., Jollès P. Identification of cyanogen bromide-fragments of the protein core of bovine nasal cartilage proteoglycan monomer. Biochim. Biophys. Acta 1983, 743:82-90.
6. Bourdon M.A., Oldberg A., Pierschbacher M., Ruoslahti E. Molecular cloning and sequence analysis of a chondroitin sulfate proteoglycan cDNA. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:1321-1325.
7. Bülow H.E., Berry K.L., Topper L.H., Peles E., Hobert O. Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6346-6351.
8. Bush K.T., Crawford B.E., Garner O.B., Nigam K.B., Esko J.D., Nigam S.K. N-sulfation of heparan sulfate regulates early branching events in the developing mammary gland. J. Biol. Chem. 2012, 287:42064-42070.
9. Carlsson P., Presto J., Spillmann D., Lindahl U., Kjellén L. Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domains. J. Biol. Chem. 2008, 283:20008-20014.
10. Casu B., Lindahl U. Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 2001, 57:159-206.
11. Chen R.L., Lander A.D. Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. J. Biol. Chem. 2001, 276:7507-7517.
12. Clement A.M., Nadanaka S., Masayama K., Mandl C., Sugahara K., Faissner A. The DSD-1 carbohydrate epitope depends on sulfation, correlates with chondroitin sulfate D motifs, and is sufficient to promote neurite outgrowth. J. Biol. Chem. 1998, 273:28444-28453.
13. Dagälv A., Holmborn K., Kjellén L., Åbrink M. Lowered expression of heparan sulfate/heparin biosynthesis enzyme N-deacetylase/N-sulfotransferase 1 results in increased sulfation of mast cell heparin. J. Biol. Chem. 2011, 286:44433-44440.
14. Danielson K.B., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibriil morphology and skin fragility. J. Cell Biol. 1997, 136:729-743.
15. David G. Integral membrane heparan sulfate proteoglycans. FASEB J. 1993, 7:1023-1030.
16. de Paz J.L., Noti C., Seeberger P.H. Microarrays of synthetic heparin oligosaccharides. J. Am. Chem. Soc. 2006, 128:2766-2767.
17. Esko J.D., Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 2002, 71:435-471.
18. Esko J.D., Stewart T.E., Taylor W.H. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:3197-3201.
19. Esko J.D., Rostand K.S., Weinke J.L. Tumor formation dependent on proteoglycan biosynthesis. Science 1988, 241:1092-1096.
20. Fongmoon D., Shetty A.K., Basappa, Yamada S., Sugiura M., Kongtawelert P., Sugahara K. Chondroitinase-mediated degradation of rare 3-O-sulfated glucuronic acid in functional oversulfated chondroitin sulfate K and E. J. Biol. Chem. 2007, 282:36895-36904.
21. Fratantoni J.C., Hall C.W., Neufeld E.F. Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science 1968, 162:570-572.
22. Hardingham T.E., Muir H. Hyaluronic acid in cartilage and proteoglycan aggregation. Biochem. J. 1974, 139:565-581.
23. Hascall V.C., Heinegård D. Aggregation of cartilage proteoglycans. I. The role of hyaluronic acid. J. Biol. Chem. 1974, 249:4232-4241.
24. Hascall V.C., Karamanos N. Regulatory roles of hyaluronan in health and disease. FEBS J. 2011, 278:1411.
25. Hassell J.R., Kimura J.H., Hascall V.C. Proteoglycan core protein families. Annu. Rev. Biochem. 1986, 55:539-567.
26. Haug A., Larsen B. Biosynthesis of alginate. Epimerisation of D-mannuronic to L-guluronic acid residues in the polymer chain. Biochim. Biophys. Acta 1969, 192:557-559.
27. Höök M., Lindahl U., Hallén A., Bäckström G. Biosynthesis of heparin. Studies on the microsomal sulfation process. J. Biol. Chem. 1975, 250:6065-6071.
28. Hopwood J.J., Morris C.P. The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment. Mol. Biol. Med. 1990, 7:381-404.
29. Hricovíni M., Guerrini M., Bisio A., Torri G., Naggi A., Casu B. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution. Semin. Thromb. Hemost. 2002, 28:325-334.
30. Iozzo R.V., Karamanos N. Proteoglycans in health and disease: emerging concepts and future directions. FEBS J. 2010, 277:3863.
31. Irie F., Badie-Mahdavi H., Yamaguchi Y. Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:5052-5056.
32. Jacobsson I., Lindahl U. Biosynthesis of heparin. Concerted action of late polymer-modification reactions. J. Biol. Chem. 1980, 255:5094-5100.
33. Kasza Z., Fredlund Fuchs P., Tamm C., Eriksson A.S., O'Callaghan P., Heindryckx F., Spillmann D., Larsson E., Le Jan S., Eriksson I., Gerwins P., Kjellén L., Kreuger J. MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA). J. Biol. Chem. 2013, 288:25956-25963.
34. Kjellén L., Lindahl U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 1991, 60:443-475.
35. Kjellén L., Pettersson I., Höök M. Cell-surface heparan sulfate: an intercalated membrane proteoglycan. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:5371-5375.
36. Kraemer P. Heparan sulfates of cultured cells. I. Membrane-associated and cell-sap species in Chinese hamster cells. Biochemistry 1971, 10:1437-1445.
37. Kreuger J., Jemth P., Sanders-Lindberg E., Eliahu L., Ron D., Basilico C., Salmivirta M., Lindahl U. Fibroblast growth factors share binding sites in heparan sulphate. Biochem. J. 2005, 389:145-150.
38. Kreuger J., Spillmann D., Li J.P., Lindahl U. Interactions between heparan sulfate and proteins: the concept of specificity. J. Cell Biol. 2006, 174:323-327.
39. Lawrence R., Brown J.R., Lorey F., Dickson P.I., Crawford B.E., Esko J.D. Glycan-based biomarkers for mucopolysaccharidoses. Mol. Genet. Metab 2013, pii: S1096-7192(13)00264-3. (Epub ahead of print). 10.1016/j.ymgme.2013.07.016.
40. Le Jan S., Hayashi M., Kasza Z., Eriksson I., Bishop J.R., Weibrecht I., Heldin J., Holmborn K., Jakobsson L., Söderberg O., Spillmann D., Esko J.D., Claesson-Welsh L., Kjellén L., Kreuger J. Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1255-1263.
41. Ledin J., Staatz W., Li J.-P., Götte M., Selleck S., Kjellén L., Spillmann D. Heparan sulfate structure in mice with genetically modified heparan sulfate production. J. Biol. Chem. 2004, 279:42732-42741.
42. Ledin J., Ringvall M., Thuveson M., Eriksson I., Wilén M., Kusche-Gullberg M., Forsberg E., Kjellén L. Enzymatically active N-deacetylase/N-sulfotransferase-2 is present in liver but does not contribute to heparan sulfate N-sulfation. J. Biol. Chem. 2006, 281:35727-35734.
43. Li J.P., Gong F., Hagner-McWhirter A., Forsberg E., Abrink M., Kisilevsky R., Zhang X., Lindahl U. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking l-iduronic acid and in neonatal lethality. J. Biol. Chem. 2003, 278:28363-28366.
44. Li F., Shi W., Capurro M., Filmus J. Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling. J. Cell Biol. 2011, 192:691-704.
45. Lidholt K., Weinke J.L., Kiser C.S., Lugemwa F.N., Bame K.J., Cheifetz S., Massagué J., Lindahl U., Esko J.D. A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:2267-2271.
46. Lindahl U., Kjellén L. Pathophysiology of heparan sulphate: many diseases, few drugs. J. Intern. Med. 2013, 273:555-571.
47. Lindahl U., Li J.P. Interactions between heparan sulfate and proteins - design and functional implications. Int. Rev. Cell Mol. Biol. 2009, 276:105-159.
48. Lindahl U., Bäckström G., Malmström A., Fransson L.Å. Biosynthesis of l-iduronic acid in heparin: epimerization of d-glucuronic acid on the polymer level. Biochem. Biophys. Res. Commun. 1972, 46:985-991.
49. Liu R., Xu Y., Chen M., Weïwer M., Zhou X., Bridges A.S., DeAngelis P.L., Zhang Q., Linhardt R.J., Liu J. Chemoenzymatic design of heparan sulfate oligosaccharides. J. Biol. Chem. 2010, 285:34240-34249.
50. Liu J., Moon A.F., Sheng J., Pedersen L.C. Understanding the substrate specificity of the heparan sulfate sulfotransferases by an integrated biosynthetic and crystallographic approach. Curr. Opin. Struct. Biol. 2012, 22:550-557.
51. Ly M., Leach F.E., Laremore T.N., Toida T., Amster I.J., Linhardt R.J. The proteoglycan bikunin has a defined sequence. Eur. J. Mass Spectrom. 2011, 17:167-176.
52. Maccarana M., Sakura Y., Tawada A., Yoshida K., Lindahl U. Domain structure of heparan sulfates from bovine organs. J. Biol. Chem. 1996, 271:17804-17810.
53. Malavaki C., Mizumoto S., Karamanos N., Sugahara K. Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease. Connect. Tissue Res. 2008, 49:133-139.
54. Malmström A., Fransson L.Å. Biosynthesis of dermatan sulfate. I. Formation of l-iduronic acid residues. J. Biol. Chem. 1975, 250:3419-3425.
55. Manon-Jensen T., Itoh Y., Couchman J.R. Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J. 2010, 277:3876-3889.
56. Merry C.L., Lyon M., Deakin J.A., Hopwood J.J., Gallagher J.T. Highly sensitive sequencing of the sulfated domains of heparan sulfate. J. Biol. Chem. 1999, 274:18455-18462.
57. Mizumoto S., Mikami T., Yasunaga D., Kobayashi N., Yamauchi H., Miyake A., Itoh N., Kitagawa H., Sugahara K. Chondroitin 4-O-sulfotransferase-1 is required for somitic muscle development and motor axon guidance in zebrafish. Biochem. J. 2009, 419:387-399.
58. Mongiat M., Sweeney S.M., San Antonio J.D., Fu J., Iozzo R.V. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 2003, 278:4238-4249.
59. Moscatello D.K., Santra M., Mann D.M., McQuillan D.J., Wong A.J., Iozzo R.V. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 1998, 101:406-412.
60. Muir H. The nature of the link between protein and carbohydrate of a chondroitin sulphate complex from hyaline cartilage. Biochem. J. 1958, 69:195-204.
61. Multhaupt H.A., Couchman J.R. Heparan sulfate biosynthesis; methods for investigation of the heparanosome. J. Histochem. Cytochem. 2012, 60:908-915.
62. Murphy K.J., Merry C.L., Lyon M., Thompson J.E., Roberts I.S., Gallagher J.T. A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase. J. Biol. Chem. 2004, 279:27239-27245.
63. Nikitovic D., Aggelidakis J., Young M.F., Iozzo R.V., Karamanos N.K., Tzanakakis G.N. The biology of small leucine-rich proteoglycans in bone pathophysiology. J. Biol. Chem. 2012, 287:33926-33933.
64. Noti C., de Paz J.L., Polito L., Seeberger P.H. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions. Chemistry 2006, 12:8664-8686.
65. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
66. Ögren S., Lindahl U. Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma. J. Biol. Chem. 1975, 250:2690-2697.
67. Ori A., Wilkinson M.C., Fernig D.G. A systems biology approach for the investigation of the heparin/heparan sulfate interactome. J. Biol. Chem. 2011, 286:19892-19904.
68. Pal S., Doganges P.T., Schubert M. The separation of new forms of the proteinpolysaccharides of bovine nasal cartilage. J. Biol. Chem. 1966, 241:4261-4266.
69. Perrimon N., Bernfield M. Cellular functions of proteoglycans - an overview. Semin. Cell Dev. Biol. 2001, 12:65-67.
70. Perrimon N., Häcker U. Wingless, hedgehog and heparan sulfate proteoglycans. Development 2004, 131:2509-2511.
71. Petitou M., Casu B., Lindahl U. 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site. Biochimie 2003, 85:83-89.
72. Pinhal M.A., Smith B., Olson S., Aikawa J., Kimata K., Esko J.D. Enzyme interactions in heparan sulfate biosynthesis: uronosyl 5-epimerase and 2-O-sulfotransferase interact in vivo. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12984-12989.
73. Presto J., Thuveson M., Carlsson P., Busse M., Wilén M., Eriksson I., Kusche-Gullberg M., Kjellén L. Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:4751-4756.
74. Reizes O., Lincecum J., Wang Z., Goldberger O., Huang L., Kaksonen M., Ahima R., Hinkes M.T., Barsh G.S., Rauvala H., Bernfield M. Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell 2001, 106:105-116.
75. Rodén L., Smith R. Structure of the neutral trisaccharide of the chondroitin 4-sulfate-protein linkage region. J. Biol. Chem. 1966, 241:5949-5954.
76. Rossi M., Morita H., Sormunen R., Airenne S., Kreivi M., Wang L., Fukai N., Olsen B.R., Tryggvason K., Soininen R. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J. 2003, 22:236-245.
77. Rudd T.R., Yates E.A. A highly efficient tree structure for the biosynthesis of heparan sulfate accounts for the commonly observed disaccharides and suggests a mechanism for domain synthesis. Mol. Biosyst. 2012, 8:1499-1506.
78. Sajdera S.W., Hascall V.C. Protein-polysaccharide complex from bovine nasal cartilage. A comparison of low and high shear extraction procedures. J. Biol. Chem. 1969, 244:77-87.
79. Silbert J.E. Biosynthesis of heparin. 3. Formation of a sulfated glycosaminoglycan with a microsomal preparation from mast cell tumors. J. Biol. Chem. 1967, 242:5146-5152.
80. Silbert J.E., DeLuca S. Formation of chondroitin sulfate by a microsomal preparation from chick embryo epiphyseal cartilage. Biochem. Biophys. Res. Commun. 1968, 31:990-995.
81. Stickens D., Brown D., Evans G.A. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis. Dev. Dyn. 2000, 218:452-464.
82. Whitelock J.M., Melrose J., Iozzo R.V. Diverse cell signaling events modulated by perlecan. Biochemistry 2008, 47:11174-11183.
83. Yamada S., Morimoto H., Fujisawa T., Sugahara K. Glycosaminoglycans in Hydra magnipapillata (Hydrozoa, Cnidaria): demonstration of chondroitin in the developing nematocyst, the sting organelle, and structural characterization of glycosaminoglycans. Glycobiology 2007, 17:886-894.
84. Yamaguchi Y., Ruoslahti E. Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation. Nature 1988, 336:244-246.
85. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990, 346:281-284.
86. Zaia J. Glycosaminoglycan glycomics using mass spectrometry. Mol. Cell. Proteomics 2013, 12:885-892.
87. Zimmermann D.R., Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 1989, 8:2975-2981.